• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛反应性 IgG 对异源 H5 疫苗加强免疫的反应受与初始株抗原相关性的影响。

Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.

机构信息

Department of Medicine, Division of Nephrology, University of Rochestergrid.16416.34 Medical Center, Rochester, New York, USA.

Informatics Core, Clinical, and Translational Science Institute, University of Rochestergrid.16416.34, Rochester, New York, USA.

出版信息

mBio. 2021 Aug 31;12(4):e0044921. doi: 10.1128/mBio.00449-21. Epub 2021 Jul 6.

DOI:10.1128/mBio.00449-21
PMID:34225490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8406322/
Abstract

Prime-boost vaccinations of humans with different H5 strains have generated broadly protective antibody levels. However, the effect of an individual's H5 exposure history on antibody responses to subsequent H5 vaccination is poorly understood. To investigate this, we analyzed the IgG responses to H5 influenza A/Indonesia/5/2005 (Ind05) virus vaccination in three cohorts: (i) a doubly primed group that had received two H5 virus vaccinations, namely, against influenza A/Vietnam/203/2004 (Vie04) virus 5 years prior and A/Hong Kong/156/1997 (HK97) 11 years prior to the Ind05 vaccination; (ii) a singly primed group that had received a vaccination against Vie04 virus 5 years prior to the Ind05 vaccination; and (iii) an H5-naive group that received two doses of the Ind05 vaccine 28 days apart. Hemagglutinin (HA)-reactive IgG levels were estimated by a multiplex assay against an HA panel that included 21 H5 strains and 9 other strains representing the H1, H3, H7, and H9 subtypes. Relative HA antibody landscapes were generated to quantitatively analyze the magnitude and breadth of antibody binding after vaccination. We found that short-interval priming and boosting with the Ind05 vaccine in the naive group generated a low anti-H5 response. Both primed groups generated robust antibody responses reactive to a broad range of H5 strains after receiving a booster injection of Ind05 vaccine; IgG antibody levels persisted longer in subjects who had been doubly primed years ago. Notably, the IgG responses were strongest against the first priming H5 strain, which reflects influenza virus immune imprinting. Finally, the broad anti-H5 IgG response was stronger against strains having a small antigenic distance from the initial priming strain. The antigenic shift and draft of hemagglutinin (HA) in influenza viruses is accepted as one of the major reasons for immune evasion. The analysis of B cell immune responses to influenza infection and vaccination is complicated by the impact of exposure history and antibody cross-reactions between antigenically similar influenza strains. To assist in such analyses, the influenza "antibody landscape" method has been used to analyze and visualize the relationship of antibody-mediated immunity to antigenic distances between influenza strains. In this study, we describe a "relative antibody landscape" method that calculates the antigenic distance between the vaccine influenza strain and other H5 strains and uses this relative antigenic distance to plot the anti-H5 IgG levels postvaccination. This new method quantitatively estimates and visualizes the correlation between the humoral response to a particular influenza strain and the antigenic distance from other strains. Our findings demonstrate the effect of a subject's H5 exposure history on H5 vaccine responses quantified by the relative antibody landscape method.

摘要

人类的 H5 加强免疫接种产生了广泛的保护性抗体水平。然而,个体 H5 暴露史对随后 H5 疫苗接种的抗体反应的影响知之甚少。为了研究这一点,我们分析了三个人群对 H5 流感 A/印度尼西亚/5/2005(Ind05)病毒疫苗接种的 IgG 反应:(i)双重免疫接种组,该组在 Ind05 疫苗接种前 5 年接受了两次 H5 病毒疫苗接种,即针对流感 A/Vietnam/203/2004(Vie04)病毒和 A/Hong Kong/156/1997(HK97)病毒;(ii)单次免疫接种组,该组在 Ind05 疫苗接种前 5 年接受了一次 Vie04 疫苗接种;和(iii)H5 无经验组,该组在 28 天内接受了两剂 Ind05 疫苗。通过针对包含 21 种 H5 株和 9 种其他 H1、H3、H7 和 H9 亚型株的 HA 面板的多重测定法估计了反应性 IgG 水平。生成相对 HA 抗体景观以定量分析接种后的抗体结合的强度和广度。我们发现,在无经验组中,用 Ind05 疫苗进行短期间隔的免疫接种和加强接种产生了低水平的抗 H5 反应。在接受 Ind05 疫苗加强注射后,两个免疫接种组均产生了针对广泛 H5 株的强大抗体反应;多年前接受双重免疫接种的受试者中 IgG 抗体水平持续时间更长。值得注意的是,IgG 反应最强的是最初免疫接种的 H5 株,这反映了流感病毒免疫印记。最后,与最初的免疫接种株抗原性距离较小的广泛抗 H5 IgG 反应更强。流感病毒的抗原转变和血凝素(HA)草案被认为是免疫逃避的主要原因之一。对流感感染和疫苗接种的 B 细胞免疫反应的分析因暴露史和抗原相似的流感株之间的抗体交叉反应而变得复杂。为了协助此类分析,已使用流感“抗体景观”方法来分析和可视化抗体介导的免疫与流感株之间的抗原距离之间的关系。在这项研究中,我们描述了一种“相对抗体景观”方法,该方法计算了疫苗流感株与其他 H5 株之间的抗原距离,并使用该相对抗原距离来绘制接种疫苗后的抗 H5 IgG 水平。这种新方法定量估计并可视化了对特定流感株的体液反应与来自其他株的抗原性距离之间的相关性。我们的发现表明,个体的 H5 暴露史通过相对抗体景观方法量化了 H5 疫苗接种反应的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/99ef619a8b0a/mbio.00449-21-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/9e9ae48c4411/mbio.00449-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/28f5f6e359e5/mbio.00449-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/9060dcf9cd67/mbio.00449-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/db860b271afc/mbio.00449-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/074a480d6ab3/mbio.00449-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/99ef619a8b0a/mbio.00449-21-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/9e9ae48c4411/mbio.00449-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/28f5f6e359e5/mbio.00449-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/9060dcf9cd67/mbio.00449-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/db860b271afc/mbio.00449-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/074a480d6ab3/mbio.00449-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/8406322/99ef619a8b0a/mbio.00449-21-f006.jpg

相似文献

1
Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.广泛反应性 IgG 对异源 H5 疫苗加强免疫的反应受与初始株抗原相关性的影响。
mBio. 2021 Aug 31;12(4):e0044921. doi: 10.1128/mBio.00449-21. Epub 2021 Jul 6.
2
H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model.H1 血凝素引发可在小鼠模型中提供针对 H5N1 挑战的长期异源亚型免疫。
mBio. 2020 Dec 15;11(6):e02090-20. doi: 10.1128/mBio.02090-20.
3
Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.接种禽类 H5 血凝素蛋白漂移变体可引发广泛的抗体反应,对同源或漂移的活 H5 流感病毒具有保护作用。
Vaccine. 2011 Nov 8;29(48):8888-97. doi: 10.1016/j.vaccine.2011.09.069. Epub 2011 Sep 28.
4
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.AS03 佐剂甲型 H5N1 流感疫苗加强免疫可改善异源加强免疫后的免疫应答动力学、幅度和持久性:一项双盲随机对照初级研究的开放性非随机扩展。
Vaccine. 2010 Jan 8;28(3):849-57. doi: 10.1016/j.vaccine.2009.10.017. Epub 2009 Oct 14.
5
A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.一种二价异源DNA病毒样颗粒初免-加强疫苗可引发针对1型和2型甲型流感病毒的广泛保护。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02052-16. Print 2017 May 1.
6
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.DNA 引物与流感疫苗免疫原性:两项 1 期开放性标签随机临床试验。
Lancet Infect Dis. 2011 Dec;11(12):916-24. doi: 10.1016/S1473-3099(11)70240-7. Epub 2011 Oct 3.
7
Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.用流感病毒H5血凝素抗原进行初次免疫接种可显著延长由异源H5加强免疫接种诱导的T细胞反应持续时间。
J Infect Dis. 2016 Oct 1;214(7):1020-9. doi: 10.1093/infdis/jiw310. Epub 2016 Jul 20.
8
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.基于改良安卡拉痘苗病毒的甲型流感病毒(H5N1)疫苗在随机 1/2a 期临床试验中诱导跨属抗体和 T 细胞反应。
J Infect Dis. 2018 Jul 13;218(4):614-623. doi: 10.1093/infdis/jiy214.
9
Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization.用MF59佐剂H5疫苗进行异源初免-加强免疫可促进针对血凝素HA1结构域的抗体亲和力成熟及广泛的H5N1跨分支中和作用。
PLoS One. 2014 Apr 22;9(4):e95496. doi: 10.1371/journal.pone.0095496. eCollection 2014.
10
Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.蛋白质微阵列分析流感病毒血凝素特异性抗体的特异性和交叉反应性。
mSphere. 2018 Dec 12;3(6):e00592-18. doi: 10.1128/mSphere.00592-18.

引用本文的文献

1
An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized trial in healthy adults.一种鼻内佐剂重组甲型H5流感候选疫苗,在一项针对健康成年人的I期随机试验中,可诱导针对多种甲型H5N1病毒分支产生广泛的初始免疫反应。
Res Sq. 2025 Mar 5:rs.3.rs-6059149. doi: 10.21203/rs.3.rs-6059149/v1.
2
Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies.老年人群疫苗研究进展:从免疫衰老的影响到接种策略
NPJ Vaccines. 2024 Apr 10;9(1):77. doi: 10.1038/s41541-024-00874-4.
3
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.

本文引用的文献

1
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.单剂 SARS-CoV-2 mRNA 疫苗接种后血清阳性者的抗体反应。
N Engl J Med. 2021 Apr 8;384(14):1372-1374. doi: 10.1056/NEJMc2101667. Epub 2021 Mar 10.
2
Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans.佐剂 H5N1 流感疫苗可增强人类的交叉反应性记忆 B 细胞和特异性幼稚 B 细胞反应。
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17957-17964. doi: 10.1073/pnas.1906613117. Epub 2020 Jul 13.
3
A Complex Dance: Measuring the Multidimensional Worlds of Influenza Virus Evolution and Anti-Influenza Immune Responses.
在猪模型中,异源初免-加强 H1N1 疫苗接种会加剧与不匹配的 H1N2 流感病毒攻击后的疾病。
Front Immunol. 2023 Oct 20;14:1253626. doi: 10.3389/fimmu.2023.1253626. eCollection 2023.
4
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.不同种属的甲型流感病毒(H7N9)疫苗初免程序后延迟加强免疫的安全性和免疫原性:一项随机临床试验。
J Infect Dis. 2024 Feb 14;229(2):327-340. doi: 10.1093/infdis/jiad276.
5
First Impressions Matter: Immune Imprinting and Antibody Cross-Reactivity in Influenza and SARS-CoV-2.第一印象很重要:流感和新冠病毒中的免疫印记与抗体交叉反应性
Pathogens. 2023 Jan 21;12(2):169. doi: 10.3390/pathogens12020169.
6
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity.抗原进化和原始抗原致敏对 SARS-CoV-2 免疫的影响。
J Clin Invest. 2023 Jan 3;133(1):e162192. doi: 10.1172/JCI162192.
7
Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains.H7N9 病毒诱导的记忆性广谱反应性抗体更有效地结合季节性 H3N2 株。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2128014. doi: 10.1080/21645515.2022.2128014. Epub 2022 Oct 5.
8
Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection.新冠疫苗接种和感染诱导产生的母乳中针对人类冠状病毒的广泛交叉反应性IgA和IgG
Vaccines (Basel). 2022 Jun 20;10(6):980. doi: 10.3390/vaccines10060980.
9
IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.针对人类贝塔冠状病毒刺突蛋白的 IgG 与 SARS-CoV-2 抗刺突 IgG 反应和 COVID-19 疾病严重程度相关。
J Infect Dis. 2022 Aug 26;226(3):474-484. doi: 10.1093/infdis/jiac022.
10
Cross-Reactivity Conferred by Homologous and Heterologous Prime-Boost A/H5 Influenza Vaccination Strategies in Humans: A Literature Review.同源和异源初免-加强A/H5流感疫苗接种策略在人类中产生的交叉反应:文献综述
Vaccines (Basel). 2021 Dec 10;9(12):1465. doi: 10.3390/vaccines9121465.
一场复杂的舞蹈:测量流感病毒进化与抗流感免疫反应的多维世界
Pathogens. 2019 Nov 15;8(4):238. doi: 10.3390/pathogens8040238.
4
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin.预先存在和新产生的人类记忆 B 细胞对流感血凝素反应的激活动态和免疫球蛋白进化。
Immunity. 2019 Aug 20;51(2):398-410.e5. doi: 10.1016/j.immuni.2019.06.024. Epub 2019 Jul 23.
5
Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates.连续读取与基于滴度的流感疫苗试验检测方法比较:敏感性、特异性和假阳性率。
Comput Math Methods Med. 2019 May 8;2019:9287120. doi: 10.1155/2019/9287120. eCollection 2019.
6
Improved Specificity and False Discovery Rates for Multiplex Analysis of Changes in Strain-Specific Anti-Influenza IgG.提高多重分析流感特异性 IgG 变化的特异性和假发现率。
Comput Math Methods Med. 2019 Apr 15;2019:3053869. doi: 10.1155/2019/3053869. eCollection 2019.
7
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.用A(H5N1)大流行性流感疫苗进行异源初免-加强免疫比同源初免-加强免疫诱导出更广泛的跨谱系抗体反应。
NPJ Vaccines. 2019 May 29;4:22. doi: 10.1038/s41541-019-0114-8. eCollection 2019.
8
Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus.季节性流感病毒感染引起的广泛血凝素特异性记忆 B 细胞扩增反映了早期生活印迹和对感染病毒的适应。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.00169-19. Print 2019 Apr 15.
9
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses.原始抗原性错误:初次接触如何塑造终身抗流感病毒免疫反应。
J Immunol. 2019 Jan 15;202(2):335-340. doi: 10.4049/jimmunol.1801149.
10
Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.开发基于下一代血凝素的具有广泛保护作用的流感病毒疫苗。
Curr Opin Immunol. 2018 Aug;53:51-57. doi: 10.1016/j.coi.2018.04.001. Epub 2018 Apr 20.